ABSTRACT:
Pneumonia is a form of acute respiratory tract infection (ARTI) that affect the lungs. when an individual has pneumonia, the alveoli in the lungs are filled with pus and fluid, which makes breathing painful and limits oxygen intake. The two vaccine that protect against pneumococcal disease are the 23-valent polysaccharide vaccine (PPV23) and the 13-valent protein –conjugated polysaccharide vaccine (PPV13), which replaced the 7-valent conjugate vaccine (PPV7) in 2010 in the United States. The polysaccharide vaccine (PPV) is T cell- independent and does not produce an anamnestic reaction; this means it does not enhance the reaction of the bodys immunologic memory and immunity may not be long –lasting. therefore, PPV is not effective in children younger than two years old, but it is approved for individuals aged two and older at risk for developing pneumonia and the vaccine is deemed more appropriate for adults (most those aged 50 years and older). On the other hand, conjugate vaccines (PVC) elicits a T cell-dependent respone and produce an anamnestic reaction that makes the vaccine more effective in infants and children younger than two years of age. Around 85% to 90% of antibiotics consumption occurs in community, with 80% of this consumption going towards treating respiratory tract infection.
Cite this article:
Sadaf Amreen. A Review on Studies and Research on Prevention of Pneumonia. A and V Pub Journal of Nursing and Medical Research. 2026;5(1):49-1. doi: 10.52711/jnmr.2026.11
Cite(Electronic):
Sadaf Amreen. A Review on Studies and Research on Prevention of Pneumonia. A and V Pub Journal of Nursing and Medical Research. 2026;5(1):49-1. doi: 10.52711/jnmr.2026.11 Available on: https://www.jnmronline.com/AbstractView.aspx?PID=2026-5-1-11
REFERENCES:
1. Anema, S. G., Lowe, E. K., and Lee, S. K. Effect of pH at heating on the acid-induced aggregation of casein micelles in reconstituted skim milk. LWT-Food Science and Technology. 2004; 37(7): 779-787.
2. Campbell, H., Duke, T., Weber, M., English, M., Carai, S., Tamburlini, G. Global initiatives for improving hospital care for children: state of the art and future prospects. Pediatrics. 2008; 121(4): e984-e992.
3. Fenn, B., Penny, M. E. Using the new World Health Organisation growth standards: differences from 3 countries. Journal of Pediatric Gastroenterology and Nutrition. 2008; 46(3): 316-321.
4. Park, Y. L., Majidi, C., Kramer, R., Bérard, P., Wood, R. J. Hyper elastic pressure sensing with a liquid-embedded elastomer. Journal of Micromechanics and Microengineering, 2010; 20(12): 125029.
5. Kaushal N, Vohora D, Jalali RK, Jha S. Prevalence of osteoporosis and osteopenia in an apparently healthy Indian population-a cross-sectional retrospective study. Osteoporosis and Sarcopenia. 2018 Jun 1; 4(2): 53-60.
6. Scott J.A., et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet. 2000; 355: 1225–1230.
7. Mulholland K. Perspectives on the burden of pneumonia in children. Vaccine. 2007; 25: 2394–2397. doi: 10.1016/j.vaccine.2006.09.007
8. Madhi S.A., Kohler M., Kuwanda L., Cutland C., Klugman K.P. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatric. Infect. Dis. J. 2006; 25: 30–36. doi: 10. 1097/01.inf.0000195787.99199.4a.
9. Kragsbjerg P., Jones I., Vikerfors T., Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax. 1995; 50: 1253–1257. doi: 10.1136/thx.50.12.1253.
10. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010; 375: 1969–87.